The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...

Serosurveys have expanded our understanding of infectious diseases in Africa, revealing the true burden of pathogens beyond ...

On January 20, Tanzania declared an outbreak of Marburg virus disease, which ended on March 13. For the U.S. clinical trial that began this week, Sabin will recruit 200 volunteers aged 18 to 70 across ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

It’s been five years since the COVID-19 pandemic changed everything—from the way we work to the way we think about global health. But what if another pandemic strikes tomorrow? Will the world be any ...

World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...

WHO Chief Dr. Tedros warns that another pandemic is inevitable, urging global preparedness. He stresses the urgency of ...

The World Health Organization (WHO) reported a suspected outbreak of Marburg Virus Disease (MVD) in the Kagera region of northwestern Tanzania, with nine people reportedly infected, of whom eight ...